LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2023 Results on August 28, 2023

Rhea-AI Summary

LifeVantage Corporation (LFVN) to release Q4 and full fiscal year 2023 financial results on August 28, 2023. Conference call details and webcast link provided. Investors can dial (877) 704-4453 (U.S.) or (201) 389-0920 (international) for the live call.

SALT LAKE CITY, Aug. 14, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes, today announced that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2023, after the stock market closes on Monday, August 28, 2023. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after the call concludes and will be available through Monday, September 4, 2023, by dialing (844) 512-2921 from the U.S. and entering confirmation code 13740609, or (412) 317-6671 from international locations, and entering confirmation code 13740609.

There will also be a simultaneous, live webcast available on the Investor Relations section of the Company's web site at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://viavid.webcasts.com/starthere.jsp?ei=1628859&tp_key=bd0872359f. The webcast will be archived for approximately 30 days.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the activation company, is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath & body, and targeted relief products. The Company’s line of scientifically-validated dietary supplements includes its flagship Protandim® family of products, LifeVantage® Omega+, ProBio, IC Bright®, Daily Wellness, Rise AM, Reset PM, and D3+ dietary supplements, the TrueScience® line of skin, hair, bath & body, and targeted relief products. The Company also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, Axio® its nootropic energy drink mixes, and PhysIQ, its smart weight management system. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Investor Relations Contact:

Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com

FAQ

When will LifeVantage Corporation release its Q4 and full fiscal year 2023 financial results?

LifeVantage Corporation will release its Q4 and full fiscal year 2023 financial results on August 28, 2023.

What time is the conference call for investors?

The conference call for investors will be at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on August 28, 2023.

How can investors participate in the live call?

Investors can dial (877) 704-4453 from the U.S. or (201) 389-0920 for international callers to participate in the live call.

Where can I find the webcast for the financial results release?

The simultaneous, live webcast will be available on the Investor Relations section of the Company's website at https://lifevantage.gcs-web.com/events-and-presentations or directly at https://viavid.webcasts.com/starthere.jsp?ei=1628859&tp_key=bd0872359f.

How long will the webcast be available?

The webcast will be archived for approximately 30 days after the release.